Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways

Hao Yuan; Xuelian Wu; Xiaomin Wang; Chengfu Yuan

doi:10.1016/j.gendis.2020.06.001

您当前的位置：

首页 >

文章列表页 >

Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways

更新时间：2022-06-24

- Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways
- Genes & Diseases Vol. 9, Issue 2, (2022)
- 作者机构：
  
  1. College of Medical Science, China Three Gorges University,Hubei,Yichang,PR China,443002
  2. BGI Education Center, University of Chinese Academy of Sciences,Guangdong,Shenzhen,PR China,518083
  3. Chumeiren Medical Cosmetic Clinic, WuJiaGang District,Hubei,Yichang,PR China,443002
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2020.06.001
  CLC：
- Published：2022，
  
  Published Online：1 March 2022，
扫描看全文
Hao Yuan, Xuelian Wu, Xiaomin Wang, et al. Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways. [J]. Genes & Diseases 9(2).(2022)
DOI：

Hao Yuan, Xuelian Wu, Xiaomin Wang, et al. Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways. [J]. Genes & Diseases 9(2).(2022) DOI： 10.1016/j.gendis.2020.06.001.

摘要

Abstract

galus and Angelica decoction (A

A) has been clinically used as a classical traditional Chinese medicine (TCM) formula in China for many years for the treatment of kidney diseases

especially renal interstitial fibrosis (RIF). However

the mechanisms underlying the therapeutic effects of A

A on RIF remains poorly understood. In the present study

systematic network pharmacology and effective experimental verification were utilized for the first time to elucidate the pharmacological efficacy and potential mechanism. The outcomes indicated that 22 active components and 87 target genes of A

A were identified and cross-referenced with RIF-associated genes

contributing to confirmation of 74 target genes of A

A for RIF. Pathway and functional enrichment analyses revealed that A

A had substantial effects on MAPK

PI3K-Akt and TNF signaling pathways. In addition

seven core targets with relatively higher betweenness and degree were identified in the constructed Chinese medicine material-chemical component-target-signal pathway network. Moreover

we verified the potential therapeutic effect of A

in vivo

(using a mouse model of RIF)

confirming that A

A could effectively protect the kidney by regulating these target genes. The therapeutic effect of A

A on RIF could be attributed to its role in regulating the cell cycle

limiting the apoptosis

and inhibiting the inflammation.

关键词

Keywords

Active componentsAstragalus and angelica decoctionNetwork pharmacologyRenal interstitial fibrosisTarget gene

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploring the mechanism of Yishen Daluo decoction in the treatment of multiple sclerosis based on network pharmacology and in vitro experiments

Pharmacodynamic evaluation of Cordyceps sinensis (Berk.) Sacc. for ischemic stroke in rats and potential mechanism through network pharmacology and molecular docking

Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future

Related Author

Qian Hua

Yan Tan

Xu Wang

Peng Wei

Zhaoheng Liu

Xinghua Wang

Qingyuan Cai

Ce Zhang

Related Institution

School of Life Sciences & School of Traditional Chinese Medicine, Beijing University of Chinese Medicine

School of Biomedical Informatics, University of Texas Health Science Center at Houston

Department of Pathology, University of California San Diego, La Jolla

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine

School of Chinese Materia Medica, Beijing University of Chinese Medicine

⁰